Pharmaco - Press Releases

Date	Title	Company
04-Nov-2025	Kyowa Kirin International Announces Appointment of Julie Dehaene-Puype as President for the Region	Kyowa Kirin
04-Nov-2025	Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids	Santhera Pharmaceuticals
31-Oct-2025	Automotive Active Health Monitoring System Market Poised for Explosive Growth, Projected to Reach USD 31.38 Billion by 2032	Ameco Research
29-Oct-2025	eschbach’s Shiftconnector® Helps Power Merck’s Visual Factory to Drive Greater Transparency, Agility, and Supply Chain Resilience	eschbach
24-Oct-2025	Nationwide Boiler Highlights the CataStak™ SCR System for Pharmaceutical Manufacturing Facilities	Nationwide Boiler
24-Oct-2025	Personalized Medicine Biomarkers Market 2025–2033: Trends, Growth Drivers, and Market Size Forecast to USD 72.06 Billion	Acumen Research And Consulting
23-Oct-2025	Novo Nordisk board changes: expert comment	Novo Nordisk, University of Bath
23-Oct-2025	Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey	Sanofi, Medidata
22-Oct-2025	Owen Mumford launches EcoSafe® safety syringe platform – smarter for budgets and kinder to the planet	Owen Mumford
21-Oct-2025	Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus	AstraZeneca
21-Oct-2025	Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment	Global Fund
21-Oct-2025	Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy	Kelso Pharma
21-Oct-2025	Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose	Sanofi
21-Oct-2025	Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program	Sanofi
21-Oct-2025	selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease	selectION, Inc.
20-Oct-2025	ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors	ImmunOs Therapeutics
15-Oct-2025	University of Huddersfield academic appointed next Chair of Academy of Pharmaceutical Sciences	Academy of Pharmaceutical Sciences
14-Oct-2025	GSK’s Shingrix approved in China for prevention of shingles in adults aged 18 and over who are at increased risk due to immunodeficiency or immunosuppression	GSK
10-Oct-2025	SMC accepts Yselty®▼ (linzagolix) with Add-back Therapy for symptomatic treatment of endometriosis in adult women of reproductive age with a history of previous medical or surgical treatment for their endometriosis	Theramex
09-Oct-2025	Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia	Santhera